Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2004-11-17
2010-10-05
Stucker, Jeffrey (Department: 1649)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S134100, C424S135100, C424S136100, C424S143100, C424S179100, C530S387100, C530S388220, C530S391100
Reexamination Certificate
active
07807154
ABSTRACT:
Antibody A or a fusion protein thereof specifically binding to a leptin receptor (leptin-R) or a leptin-binding protein (leptin-BP), as well as compositions and methods for the use of these antibodies or fusion proteins for quantitative analysis, for therapeutic purposes and for the preparation of therapeutic drugs. Also disclosed is a method for quantitative determination of leptin in a sample of solubilized or suspended leptin-binding proteins by using specific antibodies or fusion proteins according to the invention, as well as diagnostic agents and (diagnostic) kits containing this antibody or fusion protein.
REFERENCES:
patent: 7446183 (2008-11-01), Ross et al.
patent: WO 99/59614 (1999-11-01), None
Bidlingmaier Martin
Matarese Guiseppe
Ross Richard J. M.
Strasburger Christian J.
Wu Zida
Biofusion Licensing Limited
Gucker Stephen
Li Kening
Pinsent Masons LLP
Stucker Jeffrey
LandOfFree
Leptin antagonist and method for quantitative measurement of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Leptin antagonist and method for quantitative measurement of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Leptin antagonist and method for quantitative measurement of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4202547